ClinVar Miner

Submissions for variant NM_001458.5(FLNC):c.3209C>T (p.Pro1070Leu)

gnomAD frequency: 0.00005  dbSNP: rs370391049
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000649094 SCV000770919 likely benign Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant 2024-01-04 criteria provided, single submitter clinical testing
GeneDx RCV001756082 SCV001997523 uncertain significance not provided 2023-05-19 criteria provided, single submitter clinical testing Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function
Ambry Genetics RCV002325296 SCV002609338 uncertain significance Cardiovascular phenotype 2023-10-24 criteria provided, single submitter clinical testing The p.P1070L variant (also known as c.3209C>T), located in coding exon 21 of the FLNC gene, results from a C to T substitution at nucleotide position 3209. The proline at codon 1070 is replaced by leucine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Revvity Omics, Revvity RCV001756082 SCV003831459 uncertain significance not provided 2021-10-12 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003420137 SCV004113792 uncertain significance FLNC-related disorder 2023-03-28 criteria provided, single submitter clinical testing The FLNC c.3209C>T variant is predicted to result in the amino acid substitution p.Pro1070Leu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.012% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/7-128484728-C-T). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario RCV003486910 SCV004240639 uncertain significance Cardiomyopathy 2023-05-16 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.